Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.5M Sell
190,293
-4,124
-2% -$483K 0.25% 72
2026
Q1
$23.4M Buy
194,417
+13,429
+7% +$1.55M 0.26% 66
2025
Q4
$19.1M Buy
180,988
+1,339
+0.7% +$126K 0.22% 83
2025
Q3
$15.1M Sell
179,649
-9,729
-5% -$801K 0.17% 115
2025
Q2
$15M Buy
189,378
+3,917
+2% +$311K 0.18% 120
2025
Q1
$16.6M Sell
185,461
-49,315
-21% -$4.6M 0.21% 92
2024
Q4
$23.4M Sell
234,776
-23,530
-9% -$2.43M 0.29% 59
2024
Q3
$29.3M Sell
258,306
-9,519
-4% -$1.13M 0.36% 48
2024
Q2
$33.2M Sell
267,825
-4,028
-1% -$519K 0.43% 40
2024
Q1
$35.9M Buy
271,853
+17,281
+7% +$2.13M 0.49% 36
2023
Q4
$27.8M Buy
254,572
+9,005
+4% +$935K 0.43% 44
2023
Q3
$25.3M Buy
245,567
+8,804
+4% +$949K 0.45% 40
2023
Q2
$27.3M Buy
236,763
+4,728
+2% +$537K 0.49% 38
2023
Q1
$24.7M Sell
232,035
-13,190
-5% -$1.42M 0.47% 38
2022
Q4
$27.2M Buy
245,225
+10,458
+4% +$1.07M 0.56% 28
2022
Q3
$20.2M Sell
234,767
-9,903
-4% -$884K 0.45% 36
2022
Q2
$22.3M Buy
244,670
+10,715
+5% +$950K 0.47% 34
2022
Q1
$19.2M Buy
233,955
+3,329
+1% +$262K 0.34% 59
2021
Q4
$17.7M Buy
230,626
+6,128
+3% +$488K 0.32% 66
2021
Q3
$16.9M Buy
224,498
+20,611
+10% +$1.57M 0.3% 67
2021
Q2
$15.9M Sell
203,887
-1,606
-0.8% -$119K 0.31% 65
2021
Q1
$15.1M Buy
205,493
+19,151
+10% +$1.41M 0.33% 64
2020
Q4
$14.5M Buy
186,342
+17,432
+10% +$1.33M 0.35% 62
2020
Q3
$13.4M Sell
168,910
-5,390
-3% -$422K 0.41% 48
2020
Q2
$12.9M Buy
174,300
+23,742
+16% +$1.79M 0.44% 46
2020
Q1
$11.1M Sell
150,558
-20,532
-12% -$1.61M 0.85% 24
2019
Q4
$14.8M Buy
171,090
+72,631
+74% +$5.97M 0.4% 46
2019
Q3
$7.91M Buy
98,459
+2,661
+3% +$213K 0.28% 75
2019
Q2
$7.79M Buy
95,798
+14,862
+18% +$1.14M 0.29% 74
2019
Q1
$6.42M Sell
80,936
-2,830
-3% -$212K 0.27% 77
2018
Q4
$6.11M Sell
83,766
-31,082
-27% -$2.19M 0.27% 63
2018
Q3
$7.77M Sell
114,848
-4,485
-4% -$286K 0.31% 58
2018
Q2
$6.91M Sell
119,333
-9,294
-7% -$524K 0.3% 58
2018
Q1
$6.68M Buy
128,627
+36,253
+39% +$1.96M 0.32% 50
2017
Q4
$4.96M Buy
92,374
+18,649
+25% +$1.03M 0.25% 72
2017
Q3
$4.5M Sell
73,725
-4,729
-6% -$287K 0.25% 73
2017
Q2
$4.8M Buy
78,454
+3,237
+4% +$197K 0.29% 60
2017
Q1
$4.56M Buy
75,217
+5,480
+8% +$332K 0.3% 65
2016
Q4
$3.92M Buy
69,737
+19,290
+38% +$1.13M 0.3% 55
2016
Q3
$3M Buy
50,447
+13,214
+35% +$773K 0.28% 58
2016
Q2
$2.09M Sell
37,233
-20,092
-35% -$1.07M 0.23% 69
2016
Q1
$2.89M Buy
57,325
+9,729
+20% +$476K 0.33% 44
2015
Q4
$2.32M Buy
47,596
+12,912
+37% +$651K 0.26% 62
2015
Q3
$1.64M Buy
34,684
+314
+0.9% +$16.7K 0.23% 66
2015
Q2
$1.87M Sell
34,370
-167
-0.5% -$9.37K 0.22% 65
2015
Q1
$1.89M Buy
34,537
+4,598
+15% +$260K 0.21% 67
2014
Q4
$1.62M Buy
29,939
+1,492
+5% +$83.1K 0.17% 94
2014
Q3
$1.61M Buy
28,447
+1,122
+4% +$63K 0.16% 108
2014
Q2
$1.51M Buy
27,325
+2,320
+9% +$127K 0.15% 127
2014
Q1
$1.35M Buy
25,005
+1,668
+7% +$86.4K 0.14% 136
2013
Q4
$1.11M Buy
23,337
+2,273
+11% +$104K 0.11% 174
2013
Q3
$957K Sell
21,064
-6,327
-23% -$289K 0.1% 163
2013
Q2
$1.21M Buy
+27,391
New +$1.22M 0.15% 89

Other funds holding MRK

Atria Investments's MRK Position: Q2 2026 in Review

Atria Investments reduced its Merck (MRK) stake by 2.1% in Q2 2026, selling an estimated $483K and leaving 190,293 shares worth $24.5M. The position accounts for 0.25% of the portfolio, ranked #72.

Atria Investments first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.9M in Q1 2024. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Atria Investments held 190,293 shares of Merck worth $24.5M as of Q2 2026.
  • Atria Investments sold 4,124 Merck shares in Q2 2026, an estimated $483K.
  • Merck made up 0.25% of Atria Investments's portfolio in Q2 2026, its #72 holding.
  • Atria Investments first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Atria Investments's Merck position peaked at $35.9M in Q1 2024.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.